Objective To investigate the expression patterns of osteopontin (OPN) , vascular endothelial growth factor-A (VEGF-A) , and hypoxia-inducible factor-1α (HIF-1α) in primary hepatocellular carcinoma (HCC) and determine the clinical significance of this differential expression profile.Methods Immunohistochemical staining of OPN, VEGF-A, and HIF-1α was carried out on primary HCC tissues from 90 patients, HCC-adjacent cirrhosis tissues from 20 of those patients, and normal liver tissues from 15 healthy controls.Correlations between expression levels and HCC clinicopathological characteristics were assessed by Spearman's correlation coefficient.Results The majority of HCC tissues showed positive immunostaining for OPN (69/90, 76.67%) , VEGF-A (64/90, 71.11%) , and HIF-1α (66/90, 73.33%) .OPN-and VEGF-A-positivity were significantly higher than the results from the cirrhosis tissues and normal tissues.HIF-1α-positivity was similar between the HCC and cirrhosis tissues, but both were significantly different from the normal tissues.The differential expressions of OPN, VEGF-A, and HIF-1α were significantly correlated with tumor thrombus, capsular integrity, tumor differentiation and stage, and metastasis (P<0.05) .Conclusion HCC tissues overexpress OPN, VEGF-A, and HIF-1α and this differential profile may be related to HCC progression.Future investigations of this triad of factors may provide novel insights into the biological characteristics of HCC and reveal important targets of molecular therapy.
[1]EI-Serg HB, Rudolph KL.Hepatocellular carcinoma:Epide-miology and molecular carcinogensis[J].Gastroenterology, 2007, 132:2557-2576.
|
[2]Guo JH, Zhu X, Li XT.Impact of serum vascular endothelialgrowth factor on prognosis in patients with unresectable HCCafter TACE[J], Chin J cancer Res, 2012, 24 (1) :36-43.
|
[3]Rosivatz E, Becker I, Specht K, et al.Differential expressionof the epithelial-mesenchymal transition regulators Snail, SIP1, and twist in gastric cancer[J].Am J Pathol, 2002, 161 (5) :1881-1891.
|
[4]Senger DR, Wirth DF, Hynes Ro.Transformed mammaliancells secrete specific proteins and phosphoproteins[J].Cell, 1979, 16:885-893.
|
[5]Chung J, Yoon SO, Lipscomb EA, et al.The Met receptorand alpha 6 beta 4 integrin can function independently to pro-mote carcinoma invasion[J].J Biol chem, 2004, 279 (31) :32287-32293.
|
[6]Gao C, Guo H, Downey L, et al.Osteopontin-dependentCD44v6 expression and cell adhesion in HepG2 cells[J].Carcinogenesis, 2003, 24 (12) :187l-1878.
|
[7]Guo H, Marroquin CE, Wai PY, et al.Nitric oxide-depend-ent osteopontin expression induces metastatic behavior inHepG2 cells[J].Dig Dis Sci, 2005, 50 (7) :1288-1298.
|
[8]Zhang Gx, Zhao ZQ, Wang HD, et al.Enhancement of os-teopontin expression in HepG2 cells by epidemal growth fac-tor via phosphatidylinositol 3-kinase signaling pathway[J].World J Gastroenterol, 2004, 10 (2) :205-208.
|
[9]Reginato MJ, Mills KR, Paulus JK, et al.Integrins and EGFRcoordinately regulate the pro-apoptotic protein Bim to pre-vent anoikis[J].Nat Cell Biol, 2003, 5 (8) :733-740.
|
[10]刘兵团, 张国新, 郝波, 等.骨桥蛋白在肝癌患者外周血和癌组织中的含量极其临床意义[J].江苏医药, 2007, 33 (11) :1081-1083.
|
[11]郜玉峰, 李旭, 谢琴秀, 等.骨桥蛋白和CD44v6在肝癌中的表达及意义[J].中华肝脏病杂志, 2005, 13 (3) :227-228.
|
[12]陆健, 卞建民, 樊克武, 等.肝癌中骨桥蛋白和血管内皮生长因子的表达及临床意义[J].江苏医药, 2006, 32 (5) :418-420.
|
[13]Cao DX, Li ZJ, Jiang XO, et al.Osteopontin as potential bio-marker and therapeutic target in gastric and liver cancers[J].World J Gastroenterol, 2012, 18 (30) :3923-3930.
|
[14]Suzuki S, Dobashi Y, Hatakeyama Y, et al.Clinicopathologi-cal significance of platelet-derived growth factor (PDGF) -B and vascular endothelial growth factor-A expression, PDGF receptor-βphosphorylation, and microvessel densityin gastric cancer[J].BMC Cancer, 2010, 10:659.
|
[1] | Long LIU, Ke SHI, Qun ZHANG, Chongping RAN, Jie HOU, Yi ZHANG, Xianbo WANG. Risk factors for hepatocellular carcinoma in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(7): 1589-1593. doi: 10.3969/j.issn.1001-5256.2021.07.022 |
[2] | Zhen PENG, Huiming JIN, Huibin NING, Kuan LI, Jia SHANG. Value of lymphocyte subset testing in predicting HBsAg decline in chronic hepatitis B patients receiving antiviral therapy[J]. Journal of Clinical Hepatology, 2021, 37(9): 2071-2074. doi: 10.3969/j.issn.1001-5256.2021.09.014 |
[3] | Liu Li, Liu ChunYun, Du YingRong, Huang HongLi, Chen Jie, Luo Yu, Li HuiMin, Li WeiKun, Li JunYi, Yue YunXuan. Liver inflammatory activity in chronic hepatitis B patients with a low HBV DNA level and related factors[J]. Journal of Clinical Hepatology, 2019, 35(1): 77-81. doi: 10.3969/j.issn.1001-5256.2019.01.014 |
[4] | Tong Jing, Sun ZhangYu, Yang LiBing, Liang YaLin, Kang YanNan. Effect of thymosin α1 on lymphocyte subsets in patients with decompensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2132-2135. doi: 10.3969/j.issn.1001-5256.2017.11.016 |
[5] | Li YuanYuan, Wang LiFeng, Geng Hua, Yu ShuangJie, Lin Hu, Lu: Sa, Chen LiMing, Zhang Zheng, Wang FuSheng. Changes in frequencies of peripheral blood lymphocyte subsets and their clinical significance in patients with autoimmune liver diseases[J]. Journal of Clinical Hepatology, 2014, 30(5): 409-412. doi: 10.3969/j.issn.1001-5256.2014.05.006 |
[6] | Li YuanYuan, Jin Lei, He Jing, Fu JunLiang, Zhang Hui, Zhou ChunBao, Zhang Zheng, Wang FuSheng. Characterization of peripheral blood lymphocyte subsets in hepatitis C virus-infected patients[J]. Journal of Clinical Hepatology, 2013, 29(2): 132-135. |
[7] | Xu GuiJuan, Yang Qing, Chen Yang. The relation between peripheral blood cell count and liver histology in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(2): 182-184. |
[8] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[9] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[10] | Dong HongYun, Zhao GuiMing, Li Ying. Study on the relationship between inflammation activity in the liver tissues and expression of HBcAg in patients with chronic hepatits B[J]. Journal of Clinical Hepatology, 2007, 23(1): 13-14. |
[11] | Ding Hong, Lu ZhongHua, Jiang XiangHu. The relationship between the liver function and contents of serum HBVDNA and hepatic pathology in patiens with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2006, 22(3): 173-174. |
[15] | Shi Ming, Wu Zhai, Zhao LiYing, Liu HaiYan. Detection of hepatitis B virus in peripheral blood mononuclear cells and liver tissue of patients with hetatitis B[J]. Journal of Clinical Hepatology, 2005, 21(2): 75-76. |